A group of international experts is proposing a first-of-its-kind framework to prevent multiple sclerosis (MS) from ...
PERRYSBURG, Ohio — Receiving a diagnosis like multiple sclerosis can be life changing and isolating, which is why a Mercy Health doctor and MS specialist is forming the organization's first-ever MS ...
SAN DIEGO--(BUSINESS WIRE)--SEQSTER PDM Inc. (“SEQSTER”), the leading patient-centric healthcare technology company, has been selected by the Multiple Sclerosis Association of America (MSAA) for its ...
Cycle Pharmaceuticals Limited (Cycle) is pleased to announce that Cycle Vita is now available with BAFIERTAM, expanding its patient support services in MS, following the acquisition of Banner Life ...
MS meditation, whether through mindfulness, breathwork, or guided walking, can help you manage the stress of living with the disease.
People with multiple sclerosis (MS) often face higher unemployment rates. Understanding the challenges and available support can help you navigate employment and financial stability. Many people ...
Our division, working in conjunction with the UAB Multiple Sclerosis Center, fosters clinical, research and educational activities in the area of neuroimmunology with emphasis on multiple sclerosis.
—Data from this real-world study revealed that patients with MS being treated with DMTs had a disproportionally higher number of cases of herpes zoster compared with patients treated with other ...
LOUISVILLE, Ky. (WDRB) -- Blindness, hearing loss and a numb leg are just some of the symptoms a Louisville woman has faced in her decades-long battle with multiple sclerosis. Yvette Cabrera-Rojas ...
Resistance training is effective for improving gait speed in individuals with multiple sclerosis. The intensity and duration of resistance training are important factors in determining the magnitude ...
Dr. Parisa Khosravi knows exactly what her patients are going through and the shock they might experience when she delivers the diagnosis. As a neuroimmunologist at Central Texas Neurology Consultants ...
Brazilian researchers, in partnership with French institutions, have developed a tool that can predict how patients will respond to natalizumab, one of the most commonly used drugs for treating ...